<h2 dir="ltr"><strong>Pertussis</strong></h2>
<p dir="ltr"><a href="https://www.delveinsight.com/report-store/pertussis-market"><strong>Pertussis</strong></a>, commonly known as whooping cough, is a highly contagious bacterial infection of the respiratory tract caused by Bordetella pertussis.</p>
<h3 dir="ltr"><strong>Pertussis Epidemiology Segmentation</strong></h3>
<p dir="ltr">Total Pertussis Vaccination Coverage</p>
<h2 dir="ltr"><strong>Pertussis Epidemiology</strong></h2>
<ul>
<li dir="ltr" role="presentation">The total pertussis vaccinated population in the United States was estimated at approximately 20 million in 2025.</li>
<li dir="ltr" role="presentation">Among the 7MM, vaccination coverage for children is reported to be high; in comparison, booster vaccination compliance among adults is reported to be low.</li>
<li dir="ltr" role="presentation">For determining the vaccination coverage for each dose of the DTP vaccine, the WHO/UNICEF Joint Reporting Form on Immunization (JRF), along with country-specific organizations and research studies, has been considered for the 7MM.</li>
</ul>
<h2 dir="ltr"><strong>Pertussis Market</strong></h2>
<ul>
<li dir="ltr" role="presentation">CAGR of 2.7% is predicted for the market during the forecast period (2026&ndash;2036).</li>
<li dir="ltr" role="presentation">The market size in the 7MM in 2025 was estimated at approximately USD 4 billion.</li>
<li dir="ltr" role="presentation">80% of the total market share was occupied by the US in 2025.</li>
<li dir="ltr" role="presentation">In the 7MM, PENTACEL leads in market size due to high-volume pediatric use.</li>
<li dir="ltr" role="presentation">The pertussis market is experiencing steady growth driven by rising global incidence and recurring outbreaks.</li>
<li dir="ltr" role="presentation">Increasing vaccination programs and booster immunization awareness are expanding demand for both pediatric and adult vaccines.</li>
<li dir="ltr" role="presentation">Advances in acellular vaccine formulations and combination vaccines are also supporting market expansion.</li>
<li dir="ltr" role="presentation">Additionally, government funding and public health initiatives continue to strengthen the long-term market potential.</li>
<li dir="ltr" role="presentation">The first and most important rule of pertussis prevention is vaccination. Two vaccines in the United States help prevent whooping cough: DTaP and Tdap.</li>
<li dir="ltr" role="presentation">During their lifetimes, all adolescents and adults should have received at least three documented doses of a tetanus and diphtheria toxoid-containing vaccine.</li>
</ul>
<h3 dir="ltr"><strong>Pertussis Market Drivers</strong></h3>
<ul>
<li dir="ltr" role="presentation">Increasing disease awareness and surveillance are supporting higher vaccination rates and diagnosis.</li>
<li dir="ltr" role="presentation">Waning immunity and the growing need for booster vaccinations are driving continued market demand.</li>
<li dir="ltr" role="presentation">Expansion of immunization programs across pediatric and adult populations is strengthening vaccine uptake.</li>
<li dir="ltr" role="presentation">Rising healthcare spending across the globe is supporting broader access to vaccination programs.</li>
</ul>
<h3 dir="ltr"><strong>Pertussis Market Barriers</strong></h3>
<ul>
<li dir="ltr" role="presentation">Resurgence of pertussis continues to challenge disease control efforts globally.</li>
<li dir="ltr" role="presentation">Vaccine failure and waning immunity remain major concerns in long-term disease prevention.</li>
<li dir="ltr" role="presentation">Remaining gaps in pertussis control strategies continue to affect vaccination effectiveness and outbreak management.</li>
<li dir="ltr" role="presentation">Lack of proper epidemiology data limits comprehensive disease monitoring and healthcare planning.</li>
<li dir="ltr" role="presentation">Diagnostic challenges, including nonspecific symptoms and limited testing methods, hinder timely pertussis diagnosis.</li>
</ul>
<h3 dir="ltr"><strong>Emerging Pertussis Drugs</strong></h3>
<ul>
<li dir="ltr" role="presentation">LVBD</li>
<li dir="ltr" role="presentation">BPZE-1</li>
<li dir="ltr" role="presentation">LR20062</li>
<li dir="ltr" role="presentation">GC3111B</li>
<li dir="ltr" role="presentation">And others</li>
</ul>
<h3 dir="ltr"><strong>Key Pertussis Companies</strong></h3>
<ul>
<li dir="ltr" role="presentation">Sanofi</li>
<li dir="ltr" role="presentation">GSK</li>
<li dir="ltr" role="presentation">Merck</li>
<li dir="ltr" role="presentation">LG Chem</li>
<li dir="ltr" role="presentation">ILiAD Biotechnologies</li>
<li dir="ltr" role="presentation">GC BioPharma</li>
<li dir="ltr" role="presentation">And others</li>
</ul>
<p>&nbsp;</p>

Pertussis Market

Pertussis Market Infographics

Pertussis Symptoms, Treatment, epidemiology, companies, drugs, infographic is a short guide to understand the problem and market landscape